Terns Pharmaceuticals Inc — 四半期キャッシュフロー (NASDAQ:TERN) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 363.93 M339.31 M320.42 M301.65 M1.03 B 負債合計 18.06 M13.27 M15.19 M17.59 M18.55 M 純資産合計 345.87 M326.04 M305.23 M284.07 M1.01 B 負債および純資産合計 363.93 M339.31 M320.42 M301.65 M1.03 B 有利子負債合計 ————— 純負債 —————

ニュース

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know

AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Stock Market Breaks Lower As Oil Prices Rebound Amid Iran War; Arm Flexes: Weekly Review

Can MRK's Ongoing M&A Push Aid Long-Term Growth Ahead of Keytruda LOE?

Merck Stock Soars 50% in 6 Months: Buy, Hold, or Take Profits?

Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up

このクアルコムのアナリストはもはや強気ではない ; 木曜日の格下げ上位4件は以下の通り

Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK)

Why Merck Might Have A Fight On Its Hands With Its $6.7 Billion Takeover Of Terns

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal